BRPI1008941A2 - Sequência polinucleotídica e polipeptídica e métodos da mesma. - Google Patents
Sequência polinucleotídica e polipeptídica e métodos da mesma.Info
- Publication number
- BRPI1008941A2 BRPI1008941A2 BRPI1008941-1A BRPI1008941A BRPI1008941A2 BR PI1008941 A2 BRPI1008941 A2 BR PI1008941A2 BR PI1008941 A BRPI1008941 A BR PI1008941A BR PI1008941 A2 BRPI1008941 A2 BR PI1008941A2
- Authority
- BR
- Brazil
- Prior art keywords
- polynucleotide
- methods
- polypeptide sequence
- polypeptide
- sequence
- Prior art date
Links
- 102000040430 polynucleotide Human genes 0.000 title 1
- 108091033319 polynucleotide Proteins 0.000 title 1
- 239000002157 polynucleotide Substances 0.000 title 1
- 229920001184 polypeptide Polymers 0.000 title 1
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/16—Extraction; Separation; Purification by chromatography
- C07K1/18—Ion-exchange chromatography
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/62—DNA sequences coding for fusion proteins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/62—Insulins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1003—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor
- C12N15/1006—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor by means of a solid support carrier, e.g. particles, polymers
- C12N15/101—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor by means of a solid support carrier, e.g. particles, polymers by chromatography, e.g. electrophoresis, ion-exchange, reverse phase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
- C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2800/00—Nucleic acids vectors
- C12N2800/22—Vectors comprising a coding region that has been codon optimised for expression in a respective host
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Biomedical Technology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Endocrinology (AREA)
- Analytical Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Diabetes (AREA)
- Toxicology (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Mycology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN567CH2009 | 2009-03-12 | ||
| PCT/IN2010/000144 WO2010103546A2 (en) | 2009-03-12 | 2010-03-12 | A polynucleotide and polypeptide sequence and methods thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI1008941A2 true BRPI1008941A2 (pt) | 2015-09-01 |
Family
ID=42728894
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI1008941-1A BRPI1008941A2 (pt) | 2009-03-12 | 2010-03-12 | Sequência polinucleotídica e polipeptídica e métodos da mesma. |
Country Status (11)
| Country | Link |
|---|---|
| US (3) | US8575322B2 (pt) |
| EP (1) | EP2406377B1 (pt) |
| KR (1) | KR101702342B1 (pt) |
| CN (1) | CN102439154A (pt) |
| AU (1) | AU2010223154B2 (pt) |
| BR (1) | BRPI1008941A2 (pt) |
| CA (1) | CA2755300A1 (pt) |
| MY (1) | MY161552A (pt) |
| SG (1) | SG174313A1 (pt) |
| WO (1) | WO2010103546A2 (pt) |
| ZA (1) | ZA201107067B (pt) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9223951B2 (en) | 2014-02-07 | 2015-12-29 | Bank Of America Corporation | User authentication based on other applications |
| US9286450B2 (en) | 2014-02-07 | 2016-03-15 | Bank Of America Corporation | Self-selected user access based on specific authentication types |
| US9647999B2 (en) | 2014-02-07 | 2017-05-09 | Bank Of America Corporation | Authentication level of function bucket based on circumstances |
| US9208301B2 (en) | 2014-02-07 | 2015-12-08 | Bank Of America Corporation | Determining user authentication requirements based on the current location of the user in comparison to the users's normal boundary of location |
| US9721268B2 (en) | 2014-03-04 | 2017-08-01 | Bank Of America Corporation | Providing offers associated with payment credentials authenticated in a specific digital wallet |
| US9729536B2 (en) | 2015-10-30 | 2017-08-08 | Bank Of America Corporation | Tiered identification federated authentication network system |
| US10511692B2 (en) | 2017-06-22 | 2019-12-17 | Bank Of America Corporation | Data transmission to a networked resource based on contextual information |
| US10524165B2 (en) | 2017-06-22 | 2019-12-31 | Bank Of America Corporation | Dynamic utilization of alternative resources based on token association |
| US10313480B2 (en) | 2017-06-22 | 2019-06-04 | Bank Of America Corporation | Data transmission between networked resources |
| CN111094572B (zh) * | 2018-02-09 | 2023-04-04 | 江苏恒瑞医药股份有限公司 | 一种密码子优化的人胰岛素类似物前体基因和信号肽基因 |
| EP3805257A4 (en) * | 2018-05-24 | 2022-03-16 | Jiangsu Hengrui Medicine Co., Ltd. | METHOD OF PRODUCTION OF A PRECURSOR OF RECOMBINANT HUMAN INSULIN OR ANALOGUE THEREOF |
| US10799564B1 (en) | 2019-05-06 | 2020-10-13 | Baxter International Inc. | Insulin premix formulation and product, methods of preparing same, and methods of using same |
| CN115634473B (zh) * | 2022-03-09 | 2026-04-03 | 中国人民解放军海军军医大学 | 一种膜蛋白原位合成亲和生物色谱柱及其制备方法和应用 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK463887D0 (da) * | 1987-09-07 | 1987-09-07 | Novo Industri As | Gaerleader |
| DK105489D0 (da) * | 1989-03-03 | 1989-03-03 | Novo Nordisk As | Polypeptid |
| US6251856B1 (en) * | 1995-03-17 | 2001-06-26 | Novo Nordisk A/S | Insulin derivatives |
| AU2149899A (en) * | 1998-01-23 | 1999-08-09 | Novo Nordisk A/S | Process for making desired polypeptides in yeast |
| FR2810339B1 (fr) * | 2000-06-14 | 2004-12-10 | Hoechst Marion Roussel Inc | Banques combinatoires ameliorees par recombinaison dans la levure et procede d'analyse |
| WO2008134996A1 (de) * | 2007-05-03 | 2008-11-13 | Siemens Aktiengesellschaft | Verfahren zum beeinflussen von einrichtungen einer hochspannungsanlage |
| WO2008139496A1 (en) * | 2007-05-16 | 2008-11-20 | Bigtec Private Limited | Recombinant human insulin and a method thereof |
-
2010
- 2010-03-12 MY MYPI2011004302A patent/MY161552A/en unknown
- 2010-03-12 WO PCT/IN2010/000144 patent/WO2010103546A2/en not_active Ceased
- 2010-03-12 CN CN2010800204193A patent/CN102439154A/zh active Pending
- 2010-03-12 EP EP10750465.6A patent/EP2406377B1/en not_active Not-in-force
- 2010-03-12 AU AU2010223154A patent/AU2010223154B2/en not_active Ceased
- 2010-03-12 US US13/256,028 patent/US8575322B2/en active Active
- 2010-03-12 BR BRPI1008941-1A patent/BRPI1008941A2/pt not_active IP Right Cessation
- 2010-03-12 CA CA2755300A patent/CA2755300A1/en not_active Abandoned
- 2010-03-12 SG SG2011065067A patent/SG174313A1/en unknown
- 2010-03-12 KR KR1020117024002A patent/KR101702342B1/ko active Active
-
2011
- 2011-09-28 ZA ZA2011/07067A patent/ZA201107067B/en unknown
-
2013
- 2013-08-22 US US13/973,130 patent/US9309281B2/en not_active Expired - Fee Related
- 2013-08-22 US US13/973,102 patent/US9238674B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| US8575322B2 (en) | 2013-11-05 |
| AU2010223154B2 (en) | 2014-10-09 |
| SG174313A1 (en) | 2011-10-28 |
| KR20110132447A (ko) | 2011-12-07 |
| US20120077966A1 (en) | 2012-03-29 |
| EP2406377A4 (en) | 2012-12-26 |
| CN102439154A (zh) | 2012-05-02 |
| EP2406377A2 (en) | 2012-01-18 |
| ZA201107067B (en) | 2012-05-30 |
| KR101702342B1 (ko) | 2017-02-03 |
| US9309281B2 (en) | 2016-04-12 |
| AU2010223154A1 (en) | 2011-10-13 |
| WO2010103546A2 (en) | 2010-09-16 |
| MY161552A (en) | 2017-04-28 |
| WO2010103546A3 (en) | 2011-01-06 |
| US20140051842A1 (en) | 2014-02-20 |
| US20140057318A1 (en) | 2014-02-27 |
| CA2755300A1 (en) | 2010-09-16 |
| US9238674B2 (en) | 2016-01-19 |
| EP2406377B1 (en) | 2016-01-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI1008941A2 (pt) | Sequência polinucleotídica e polipeptídica e métodos da mesma. | |
| BRPI1010301A2 (pt) | composição. | |
| HUE036081T2 (hu) | Mirac proteinek | |
| HUE032929T2 (hu) | Bifunkcionális polipeptidek | |
| BRPI1016079A2 (pt) | escaneamento antivírus. | |
| BRPI1008709A2 (pt) | composições e usos das mesmas. | |
| BRPI1016117A2 (pt) | derivados de isoxazol-isoxazol e isoxasol-isotiazol. | |
| PT2464370T (pt) | Péptidos vasoativos intestinais modificados | |
| BR112012000281A2 (pt) | proteína quimérica. | |
| BR112012002877A2 (pt) | dilatador e conjunto. | |
| IT1396487B1 (it) | Convogliatore. | |
| BRPI1010661A2 (pt) | peptídeo | |
| DK2391893T3 (da) | Lyofiliseret dabigatran | |
| BR112012002612A2 (pt) | calha. | |
| BR112012000565A2 (pt) | ensaio de vírus. | |
| BRPI1008596A2 (pt) | sistema, e, aparelho | |
| FR2942385B1 (fr) | Grille-pain. | |
| BR112012003860A2 (pt) | Combinação, e, composição nutricional | |
| IT1395137B1 (it) | Nuovi peptidi antipatogeni | |
| FR2944701B1 (fr) | Composition coloree. | |
| FR2943510B1 (fr) | Ombrelle. | |
| BR112012000911A2 (pt) | biomarcador. | |
| ES1071381Y (es) | Jamonero basculante | |
| ITRM20090257A1 (it) | Trocar. | |
| BRPI1006779A2 (pt) | polipeptídeo isolado, polinucleotídeo isolado,método de isolamento de polipeptídeo e preparação. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 9A ANUIDADE. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2505 DE 08-01-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |